Skip to main content

Year: 2023

Vivoryon Therapeutics N.V. to Present at Upcoming Investor Conference

Vivoryon Therapeutics N.V. to Present at Upcoming Investor Conference Halle (Saale) / Munich, Germany, November 7, 2023 – Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon), a clinical stage company focused on the discovery and development of small molecule medicines to modulate the activity and stability of pathologically altered proteins, today announced that the Company’s management will present at the following conference: Jefferies London Healthcare Conference (November 14-16, 2023)Date: November 14, 2023Presentation Time: 11:30 am GMT in Track 7Venue: London, UKPresenter: Dr. Frank Weber, CEO of Vivoryon Therapeutics A webcast of the presentation will be available via the “Presentations & Webcasts” page in the Investor Relations section on the Company’s website at www.vivoryon.com...

Continue reading

Eezy Plc’s Interim Report 1-9/2023: Revenue and EBIT continued to decrease – we build stronger Eezy

EEZY PLC —   INTERIM REPORT   — 7 NOVEMBER 2023 AT 8:00 Eezy Plc’s Interim Report 1–9/2023: Revenue and EBIT continued to decrease – we build stronger Eezy July–September 2023Revenue was EUR 56.0 million (EUR 67.3 million in July–September 2022). Revenue decreased by 17%. EBITDA was EUR 4.4 million (6.8). EBIT was EUR 2.3 million (4.7) and was 4.1% of revenue (7.0%). Earnings per share was EUR 0.05 (0.14). A profitability improvement program and the strategy renewal project were started during the period.January–September 2023Revenue was EUR 166.8 million (EUR 185.4 million in January–September 2022). Revenue decreased by 10%. EBITDA was EUR 11.0 million (13.6). EBIT was EUR 4.7 million (7.3) and was 2.8% of revenue (3.9%). Earnings per share was EUR 0.08 (0.21).Outlook for 2023 (since 7 August 2023) Eezy does...

Continue reading

WISeKey’s Subsidiary WISeSAT.space Ushers a New Era of Smart Containers, Deploying its Cutting Age Track & Trace Technology for Caspian Container Company SA, a Container Logistics Arm of Integral Group

WISeKey’s Subsidiary WISeSAT.space Ushers a New Era of Smart Containers, Deploying its Cutting Age Track & Trace Technology for Caspian Container Company SA, a Container Logistics Arm of Integral Group All parties are inviting industry players to work together to shape the containers’ market by joining an industry-first consortium: the agreement to be signed at the Global Freight Summit (GFS) combined with the Caspian Week Forum, which will take place during November 15-17, 2023, in Dubai, UAEGeneva, November 7, 2023 – WISeKey International Holding Ltd. (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a leader in cybersecurity, digital identity, and Internet of Things (IoT) solutions operating as a holding company, today announced that in a transformative move set to revolutionize the logistics arena, its subsidiary WISeSAT.Space, a forerunner...

Continue reading

WISeKey’s Subsidiary, SEALSQ Corp Announces New Board Member

WISeKey’s Subsidiary, SEALSQ Corp Announces New Board Member Geneva – November 7, 2023: WISeKey International Holding Ltd. (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), leader in cybersecurity, digital identity, and Internet of Things (IoT) solutions operating as a holding company, today announced that SEALSQ Corp (Nasdaq: LAES) (“SEALSQ”), its semiconductors subsidiary, has appointed Ruma Bose to its Board of Directors. Ms. Bose is an executive, entrepreneur, investor, and best-selling author. Until recently, she was Chief Growth Officer (CGO) at Clearco as it became a SoftBank-backed fintech unicorn and the world’s largest e-commerce investor. She served as Chair of CogX 2023, Europe’s largest conference on Artificial Intelligence. Previously, Ms. Bose was President of Chobani Ventures and the Chobani Foundation. She is also the co-author...

Continue reading

Elis: Share capital increase reserved for employees “Elis for All 2023”

Share capital increase reserved for employees “Elis for All 2023” Saint-Cloud, November 7, 2023 – Elis announces the end of the subscription period for the share capital increase reserved for its employees on 4 October 2023. 3.94 % of employees in 18 countries chose to participate, either directly or via the Elis Group employee shareholding fund, in this operation, the third of its kind in the Group’s history, for a total subscription of over 8 million euros. Implemented by the Elis Supervisory Board on December 12, 2022 and the Management Board on March 16, 2023, on the basis of a delegation of authority from the General Meeting of May 19, 2022 (France) and from the General Meeting of May 25, 2023 (international), the share capital increase allowed the Group’s employees to invest in Elis shares at a unit price of 12.13 euros,...

Continue reading

Capgemini delivers a solid Q3 performance with growth of +2.3% at constant exchange rates

Media relations:Victoire GruxTel.: +33 6 04 52 16 55victoire.grux@capgemini.com Investor relations:Vincent BiraudTel.: +33 1 47 54 50 87vincent.biraud@capgemini.com Capgemini delivers a solid Q3 performance with growth of +2.3% at constant exchange ratesRevenues of €5,480 million in Q3 2023, up +2.3% at constant exchange rates* Revenues of €16,906 million in the first nine months, up +6.0% at constant exchange ratesParis, November 7, 2023 – The Capgemini Group reported consolidated revenues of €5,480 million in Q3 2023, down -1.3% at current exchange rates and up +2.3% at constant exchange rates* year-on-year. Aiman Ezzat, Chief Executive Officer of the Capgemini Group, commented: “The Group delivered a solid performance in the third quarter in a challenging economic environment. The dual transition to a digital and sustainable economy...

Continue reading

Mithra’s NEXTSTELLIS® granted additional patent in the United States

                                                          Mithra’s NEXTSTELLIS® granted additional patent in the United StatesNew patent extends protection for NEXTSTELLIS® (ESTELLE®) until 2036 Mayne Pharma has a 20-year exclusive license and supply agreement in the US and Australia for NEXTSTELLIS®Liege, Belgium, 07 November 2023 – 07:00 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, announces today that it has been granted an additional patent for NEXTSTELLIS® (3 mg drospirenone and 14.2 mg estetrol (E4) tablets) in the United States. Granted by the United States Patent and Trademark Office, the new patent will provide NEXTSTELLIS® with oral-dosage-unit protection in the US market until 2036. The patent is a continuation of U.S. Patent No. 11,147,771, which covers the composition of NEXTSTELLIS®...

Continue reading

CoinShares Announces Q3 2023 Results

7th November 2023 | SAINT HELIER, Jersey | CoinShares International Limited (“CoinShares” or “the Company”) (Nasdaq Stockholm: CS; US OTCQX: CNSRF), the leading European alternative asset manager specialising in digital assets, has today published its results for the quarter ending 30th September 2023. Jean-Marie Mognetti, Chief Executive Officer of CoinShares said: “Recent developments in the digital asset sector confirm our original conviction that crypto will be integrated into institutional frameworks and that regulatory oversight is critical to this. The convergence of TradFi and digital asset systems has accelerated leading to an increased price action and the appearance of decoupling signals between Bitcoin and leading equity indices. We continued to execute on our strategy and delivered combined revenue, gains and income...

Continue reading

CNH Industrial announces voluntary delisting from Euronext Milan and single listing on the New York Stock Exchange; CNH further announces up to $1 Billion Share Buyback Program

Basildon, November 7, 2023 CNH Industrial N.V. (NYSE: CNHI / MI: CNHI) announces today that its Board of Directors has approved an application to delist its ordinary shares from Euronext Milan. Such application will be filed today. As announced on February 2, 2023, the decision to delist from Euronext Milan and concentrate its listing on NYSE was taken following a careful review of the relative trading volumes on the two exchanges. Since the spin-off in January 2022 of CNH’s On-Highway activities and the creation of Iveco Group, the majority of CNH stock trading has progressively shifted to the New York Stock Exchange (NYSE), revealing that the Company’s business profile and investor base fit better with a single US listing. Concentrating trading in one market should allow for increased liquidity and investor focus, while further simplifying...

Continue reading

Hexagon Purus ASA: Results for the third quarter 2023

Selected key developments in Q3 2023 and after balance sheet date:All-time high quarterly revenue of NOK 380 million in the third quarter of 2023, corresponding to a year-over-year revenue growth of 71%. Consequently, revenue year-to-date as of the third quarter of 2023 was NOK 954 million, up 61% year-over-year Received purchase orders in October worth EUR 6.4 million from Solaris for delivery of hydrogen fuel storage systems for transit buses to be deployed in Italy Inaugurated the Company’s new state-of-the-art hydrogen cylinder production hub in Kassel, Germany Entered into a 10-year lease agreement for a vehicle integration facility in Dallas, Texas to support the two major vehicle integrations contracts announced in 2023 Exited the quarter with order backlog consisting of firm purchase orders of approximately NOK 1.1 billion“We...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.